biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by buddy2021on Dec 20, 2018 6:53pm

111 Views

Post# 29143708

RE:A Special Thank You In Advance

Everyone has an opinion but one thing that's certain is that it's been a tough road and has taken longer than any of us wanted. I like RC and appreachiate the work he did including acknowledging it was time to prove out the science.

Under the new regime were told out of the gate that they would need time. The first deal did get signed in 2018. That's a huge milestone! And management is optimistic it will lead the way to more licensing deals. Each licence will build confidence, finance the science and the stock prices will reflect.

My nature is to be optimisic. For the patients waiting for a cure, the people who support this science that will hopefully help them and those who felt, for whatever reason, they couldn't hang in there anymore.... may you find success however you meassure it.
All the Best in 2019!

Bullboard Posts

Paramount Resources signs $3.32 billion asset sale